A Quick Audience Breakdown
Take a sneak preview at the 100+ senior liquid biopsy decision-makers joining us for the 5th anniversary edition of the Liquid Biopsy for Precision Oncology Summit East Coast.
2026 Attendee Profile
Seniority of Attendees
Promising to be our largest and most influential meeting to date, this year we will welcome an audience of 60% Director-level or above, with expertise spanning LBx, CDx, clinical biomarkers, translation, formulation, bioinformatics, clinical development, data science, diagnostics, product development, early detection and more.
Company Types Attending
With an audience already boasting 50+ industry-leading pharma, biotech and diagnostic organizations look forward to uniting with AbbVie, Alentis Therapeutics, Astellas Pharma, Bayer, BioNTech, Bristol Myers Squibb, GSK, Moderna, NIST, Novartis, Pfizer, Servier, Takeda, TransCode Therapeutics and more.
*Statistics taken from the 4th Liquid Biopsy for Precision Oncology Summit East Coast
Who You Could Connect With
Delve into the Brand-New Agenda
- Find the full speaker faculty, featuring senior leaders from Pfizer, AbbVie, Takeda, AstraZeneca, GSK and more
- Plan your 2026 experience, identify the sessions you cannot miss and map the partners to meet
- Gain exclusive insights into MRD as a regulatory endpoint, ctDNA-driven dose optimization, and AI-integration in precision oncology pipelines
- Unpack the complete details of our in-depth Pre-Conference Engager Sessions and register your interest before spots are filled
Explore the New Agenda
Discover the latest breakthroughs in ctDNA, MRD, methylation and multi-omic profiling through a focused program of expert presentations, interactive roundtables and strategic panel discussions driving precision oncology forward.
Stand at the Forefront of Liquid Biopsy Innovation
Position your solutions alongside leading diagnostic and technology providers to ensure your brand is central to the conversations shaping the next generation of oncology drug development.
Join Senior Biopharma & Diagnostic Leaders
Engage with decision-makers across translational medicine, precision oncology and clinical development, and build high-value connections during dedicated networking sessions designed to foster collaborations.